Ed Stanley: Weight Loss Drugs and the Global Economy

This podcast episode explores the implications of the rising adoption of anti-obesity drugs, known as GLP-1s, on various industries, economies, and global health. GLP-1s have the potential to address the economic burden of obesity and impact businesses, consumer behavior, and various sectors such as alcohol beverages, food retail, and fast food. The long-term effects of these drugs are being examined, including their impact on indulgent foods, insulin usage, and the prevalence of obesity-related diseases.